Evidence map›Paper›PMID 35818551›Full record

ArticleJACC. CardioOncology2022

Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors: A Systematic Review and Meta-Analysis.

Reza Fakhraei, Serena S Peck BKin, Husam Abdel-Qadir, Paaladinesh Thavendiranathan, Catherine M Sabiston, Fernando Rivera-Theurel, Paul Oh, Ani Orchanian-Cheff, Leanna Lee, Scott C Adams

Open access · goldAbstract read
In one paragraph

Article in JACC. CardioOncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Research Priorities and Future Directions in Cardio-Oncology.Current treatment options in oncology · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Reza FakhraeiTemerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Serena S Peck BKinTemerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Husam Abdel-QadirTed Rogers Cardiotoxicity Prevention Program, University Health Network, Toronto, Ontario, Canada.
Paaladinesh ThavendiranathanTed Rogers Cardiotoxicity Prevention Program, University Health Network, Toronto, Ontario, Canada.
Catherine M SabistonFaculty of Kinesiology and Physical Education, University of Toronto, Toronto, Ontario, Canada.
Fernando Rivera-TheurelTed Rogers Cardiotoxicity Prevention Program, University Health Network, Toronto, Ontario, Canada.
Paul OhCardiology, Peter Munk Cardiac Center, University Health Network, Toronto, Ontario, Canada.
Ani Orchanian-CheffLibrary and Information Services, University Health Network, Toronto, Ontario, Canada.
Leanna LeeTed Rogers Cardiotoxicity Prevention Program, University Health Network, Toronto, Ontario, Canada.
Scott C AdamsTed Rogers Cardiotoxicity Prevention Program, University Health Network, Toronto, Ontario, Canada.
University Health Network · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac rehabilitation (CR) is endorsed to improve cardiovascular outcomes in cancer survivors. The quality of CR-based research in oncology has not been assessed. Objectives: The aim of this study was to evaluate the quality of reporting and evidence from CR-based intervention studies in oncology and to explore associations between intervention participation and outcomes. Methods: Systematic searches of 5 databases were conducted (January 2020) and updated (September 2021). Randomized and nonrandomized studies evaluating CR-based interventions in adult cancer survivors during and after treatment were eligible. Independent reviewers extracted data using 2 reporting guidelines (Template for Intervention Description and Replication and Consolidated Standards for Reporting Trials Harms extension), risk of bias (ROB) assessment tools (Cochrane ROB 2.0 and Cochrane Risk of Bias in Non-Randomized Studies of Interventions), and a combined inventory (Tool for the Assessment of Study Quality and reporting in Exercise). A meta-analysis was used to explore pre-intervention/post-intervention differences for commonly assessed outcomes. Results: Ten studies involving data from 685 survivors were included. The mean quality scores for intervention reporting (Template for Intervention Description and Replication) and harms (Consolidated Standards for Reporting Trials Harms extension) were 62% and 17%, respectively. There was moderate-to-high ROB across nonrandomized (Cochrane Risk of Bias in Non-Randomized Studies of Interventions score: 25%) and randomized (ROB 2.0 score: 50%) studies. The mean standardized cardiorespiratory fitness was higher (0.42; 95% CI: 0.27-0.57), fatigue was lower (-0.45; 95% CI: -0.55 to -0.34), and percent body fat (0.07; 95% CI: -0.23 to 0.38) was not different in survivors completing CR compared with those not completing CR. Conclusions: CR-based studies in oncology have low-to-moderate reporting quality and moderate-to-high ROB limiting interpretation, reproducibility, and translation of this evidence into practice.

Indexed as

biasbiomedical research standardscardiologyCONSORT, Consolidated Standards for Reporting TrialsCR, cardiac rehabilitationCRF, cardiorespiratory fitnessCVD, cardiovascular diseasedata reportingexercise therapyoncologyRCT, randomized controlled trialROBINS-I, Cochrane Risk of Bias in Non-Randomized Studies of InterventionsROB, risk of biasTESTEX, Tool for the Assessment of Study Quality and Reporting in ExerciseTIDieR, Template for Intervention Description and ReplicationVo2peak, peak oxygen consumption

Identifiers

PMID35818551
PMCPMC9270627
OpenAlexW4283258619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.